Patent · US Active

Linear and cyclic melanocortin receptor-specific peptidomimetics

US8114844B2 · kind B2 · utility

13Cited by
9References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 3, 2008
Grant dateFeb 14, 2012
Priority date
Expiry dateOct 15, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/58
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Linear and cyclic peptidomimetics which bind to one or more melanocortin receptors are provided, which peptidomimetics include at least one ring-constrained amino acid surrogate of formula I:where R1, R2, R3, R4, R5, R6, R7, R8, and y are as defined in the specification, together with methods for synthesizing ring-constrained amino acid surrogates of formula I and peptidomimetics incorporating the same, and methods of use of peptidomimetics in the treatment of various diseases, syndromes and conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.